title: Effects of Aicardi-Goutières syndrome mutations predicted from ADAR-RNA structures.
abstract: Adenosine (A) to inosine (I) RNA editing is important for life in metazoan organisms. Dysregulation or mutations that compromise the efficacy of A to I editing results in neurological disorders and a shorten life span. These reactions are catalyzed by adenosine deaminases acting on RNA (ADARs), which hydrolytically deaminate adenosines in regions of duplex RNA. Because inosine mimics guanosine in hydrogen bonding, this prolific RNA editing alters the sequence and structural information in the RNA landscape. Aicardi-Goutières syndrome (AGS) is a severe childhood autoimmune disease that is one of a broader set of inherited disorders characterized by constitutive upregulation of type I interferon (IFN) referred to as type I interferonopathies. AGS is caused by mutations in multiple genes whose protein products, including ADAR1, are all involved in nucleic acid metabolism or sensing. The recent crystal structures of human ADAR2 deaminase domain complexed with duplex RNA substrates enabled modeling of how AGS causing mutations may influence RNA binding and catalysis. The mutations can be broadly characterized into three groups; mutations on RNA-binding loops that directly affect RNA binding, "second-layer" mutations that can alter the disposition of RNA-binding loops, and mutations that can alter the position of an α-helix bearing an essential catalytic residue.
authors.affiliation: a Department of Chemistry , University of California , Davis , CA , USA.|b Department of Molecular and Cellular Biology , University of California , Davis , CA , USA.
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Fisher
authors.affiliation: a Department of Chemistry , University of California , Davis , CA , USA.
authors.forename: Peter A
authors.initials: PA
authors.lastname: Beal
mesh_terms: D000243:Adenosine Deaminase / Q000737:chemistry / Q000378:metabolism*; D020274:Autoimmune Diseases of the Nervous System / Q000235:genetics* / Q000378:metabolism*; D020134:Catalytic Domain; D006801:Humans; D009154:Mutation; D009421:Nervous System Malformations / Q000235:genetics* / Q000378:metabolism*; D011485:Protein Binding; D054730:Protein Interaction Domains and Motifs / Q000235:genetics; D012313:RNA / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism*; D017393:RNA Editing; D016601:RNA-Binding Proteins / Q000737:chemistry / Q000378:metabolism; D013329:Structure-Activity Relationship
chemical_list: D016601:RNA-Binding Proteins; D012313:RNA; C567955:ADARB1 protein, human; D000243:Adenosine Deaminase
keywords: ADAR; Aicardi-Goutieres Syndrome; base-flipping; A to I; inosine; RNA editing